Jefferies Upgrades Metabolix (MBLX) to Buy
More News related to MBLX
- Metabolix (MBLX) Reports Wider Than Expected Q3 Loss
- Metabolix Reports Third Quarter 2008 Financial Results and Provides Business Update
- Reminder - Metabolix to Conduct a Webcast of Its Third Quarter 2008 Earnings Call
- Metabolix Hires to Support Technology Development of Mirel(TM) Bioplastics
- Metabolix Announces that Mirel(TM) Bioplastic Resins are Certified to European Vincotte Biodegradability for Soil and Fresh Water Standards
More News related to Upgrades
- BMO Upgrades Spectrum Brands (SPC) to Market Perform
- Maxim Upgrades Palomar Medical (PMTI) to Buy
- RBC Capital Upgrades DSP Group (DSPG) to Sector Perform
- UBS Upgrades Morgans Hotel Group (MHGC) to Buy
- Janney Montgomery Scott Upgrades Wright Express Corp (WXS) to Buy.
Jefferies & Co. upgrades Metabolix (Nasdaq: MBLX) from Hold to Buy.
Metabolix, Inc., a biotechnology company, develops alternatives to petrochemical-based plastics, chemicals, and energy.
Related Categories
UpgradesStocks Mentioned
-0.20Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
